Markets:

Overview

News

Currencies

International

Treasuries

Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)

112.45 -0.07 (-0.06%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rhythm Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 02, 2022

Via Benzinga

Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition ↗

August 02, 2022

Via Benzinga

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

Why Shares Of Rhythm Pharmaceuticals Are Soaring ↗

July 20, 2022

Rhythm Pharmaceuticals, Inc.

Via Benzinga

Why U.S. Stocks Are Trading Lower; Job Openings Drop To This Level In June ↗

August 02, 2022

U.S. stocks traded lower this morning, with the Dow Jones falling more than 250 points on Tuesday.

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Rhythm Pharmaceuticals: Q2 Earnings Insights ↗

August 02, 2022

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Rhythm Pharmaceuticals's Earnings: A Preview ↗

August 01, 2022

Rhythm Pharmaceuticals (NASDAQ:RYTM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Rhythm Pharma's Setmelanotide Shows Encouraging Action In Hypothalamic Obesity Study ↗

July 12, 2022

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of The Day Summary ↗

July 22, 2022

Via Benzinga

Rhythm Has Tripled In A Week And Quintupled Since May — Here's Why ↗

July 21, 2022

The company looks to take on behemoths Novo Nordisk and Eli Lilly in obesity drugs.

Via Investor's Business Daily

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday ↗

July 21, 2022

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Via Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 20, 2022

Via Benzinga

Stocks Shift Higher as Strong Earnings Continue ↗

July 20, 2022

The broader market has rebounded from this morning's losses midday.

Via Talk Markets

This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 20, 2022

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...

Via Benzinga

Tech Shares Move Higher, Nasdaq Jumps 200 Points ↗

July 20, 2022

U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining more than 200 points on Wednesday.

Via Benzinga

Rhythm Shares Shoot Higher Following Pre-marketing Authorization From French Regulatory For Multisystem Disorder Candidate ↗

July 20, 2022

The French National Agency for Medicines and Health Products Safety (ANSM) and Haute Autorité de santé (HAS) have granted pre-marketing authorization AP1 (early access authorization), for Rhythm...

Via Benzinga

Recap of Monday's Biotech Catalysts - End of the Day Summary ↗

July 18, 2022

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 15, 2022

Via Benzinga

Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday ↗

July 18, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 13, 2022

Via Benzinga

Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗

July 14, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket ↗

July 13, 2022

Gainers

Via Benzinga

Boeing, PriceSmart And 80 Biggest Movers From Yesterday ↗

July 13, 2022

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Via Benzinga

Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher ↗

July 12, 2022

U.S. stocks traded mixed toward the end of trading after recording losses in the previous session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 12, 2022

Via Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session ↗

July 12, 2022

Gainers

Via Benzinga

Rhythm Shares Climb Following Positive Interim Results From Mid-Stage Obesity Study ↗

July 12, 2022

Rhythm Pharmaceuticals (NASDAQ: RYTM) announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyperphagia in people living with...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 07, 2022

Gainers

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)

All News about Rhythm Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today